Comments
Loading...
Atea Pharmaceuticals (AVIR) Forecast
NewsEarningsAtea Pharmaceuticals (AVIR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAtea Pharmaceuticals (NASDAQ:AVIR) Stock Quotes, Forecast and News Summary
Atea Pharmaceuticals Stock (NASDAQ: AVIR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atea Pharmaceuticals (AVIR) stock?
You can purchase shares of Atea Pharmaceuticals (NASDAQ:AVIR) through any online brokerage.
Who are Atea Pharmaceuticals (AVIR) competitors?
Other companies in Atea Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Neumora Therapeutics (NASDAQ:NMRA) and Terns Pharma (NASDAQ:TERN).
What is the forecast, or price target, for Atea Pharmaceuticals (AVIR) stock?
Atea Pharmaceuticals has a consensus price target of $6.44.
What is the current price for Atea Pharmaceuticals (AVIR)?
The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $3.122 last updated February 21, 2025 at 10:46 AM EST.
Does Atea Pharmaceuticals (AVIR) pay a dividend?
There are no upcoming dividends for Atea Pharmaceuticals.
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
Atea Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Atea Pharmaceuticals (AVIR) going to split?
There is no upcoming split for Atea Pharmaceuticals.
What sector and industry does Atea Pharmaceuticals (AVIR) operate in?
Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.